Stock listing
Basilea Pharmaceutica Ag
Selected listing: A0B9GA · LSX · EUR · DE
Basilea Pharmaceutica Ag (LS Exchange: A0B9GA), Health Technology. Latest release Sep 14, 2026: Basilea announces start of clinical study by partner Asahi…
- Ticker
- LS Exchange: A0B9GA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS Exchange
- Currency
- EUR
About Basilea Pharmaceutica Ag
The company focuses on the development and commercialization of innovative therapies for the treatment of serious infections and cancer. Basilea is committed to advancing its pipeline of pharmaceutical products to address unmet medical needs.
Latest news from Basilea Pharmaceutica Ag
Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
September 14, 2026
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
August 18, 2026
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
August 5, 2026
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
July 29, 2026
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
Events
Replays
Basilea Pharmaceutica AG (0QNA) Q2 2026 Earnings Call
Tue, Aug 18, 2026 · 10:00 AM ET
Watch
Research Basilea Pharmaceutica Ag
Basilea Pharmaceutica Ag company profile
View the public company page for Basilea Pharmaceutica Ag on 6ix.
Basilea Pharmaceutica Ag news
Read company news and market updates connected to Basilea Pharmaceutica Ag.
Basilea Pharmaceutica Ag investor events
Find investor webinars, events, and replay context for Basilea Pharmaceutica Ag.
Alternate listings
BSLN:SIX
CH · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
0QNA:LSE
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:GETTEX
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
BSLNZ:AQUISUK
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
BPMUF:OTC
US · USD
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
A0B9GA:LS
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:TRADEGATE
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:BX
CH · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:MUN
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
BSLNZ:TURQUOISE
GB · CHF
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:DUS
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.
PK5:FWB
DE · EUR
Alternate listing for Basilea Pharmaceutica Ag; the primary context on this page is A0B9GA:LSX.